Background
CFO at Quintile Bio, where I'm building the finance function ahead of our Series A. Over the last fifteen years I've led finance through four UK biotech fundraises — from seed at Arclight Pharma through to Series B at Northlight Genomics — and I currently chair the audit and risk committee at Stellaris Bio. Oncology an…
Career History
Sitting CFO at a 9-person pre-Series A oncology platform out of Edinburgh BioQuarter, currently building the Series A deck targeting a £22M raise in 2026.
Chaired the audit and risk committee through a £40M Series B and PwC auditor transition at a 60-person antibody discovery company.
Led the £35M Series B in 2022 with Cambridge Innovation Capital and Abingworth, scaling finance from a single bookkeeper to a five-person function across two GMP sites.